Literature DB >> 34070336

Characteristics of Moyamoya Disease in the Older Population: Is It Possible to Define a Typical Presentation and Optimal Therapeutical Management?

Ignazio G Vetrano1, Anna Bersano2, Isabella Canavero2, Francesco Restelli1, Gabriella Raccuia1, Elisa F Ciceri3, Giuseppe Faragò3, Andrea Gioppo3, Morgan Broggi1, Marco Schiariti1, Laura Gatti4, Paolo Ferroli1, Francesco Acerbi1,5.   

Abstract

Whereas several studies have been so far presented about the surgical outcomes in terms of mortality and perioperative complications for elderly patients submitted to neurosurgical treatments, the management of elderly moyamoya patients is unclear. This review aims to explore the available data about the clinical manifestation, characteristics, and outcome after surgery of older patients with moyamoya arteriopathy (MA). We found only two articles strictly concerning elderly patients with MA. We have also evaluated other reported adult series of moyamoya patients, including elderly cases in their analysis. Patients with MA above 50 years old may be considered a peculiar subset in which patients are often presenting with ischemic symptoms and a higher Suzuki grade. Conservative treatment may be proposed in asymptomatic or stable cases due to their fragility and possible increase of post-operative complications, while the best surgical options in symptomatic cases are still under investigation, although we believe that a minimal invasive superficial temporal artery-middle cerebral artery bypass could be considered the treatment of choice for the immediate effect on brain perfusion with a limited rate of post-operative complications.

Entities:  

Keywords:  cerebral angiopathy; elderly; extracranial-intracranial bypass; internal carotid artery; middle cerebral artery; moyamoya; revascularization; superficial temporal artery

Year:  2021        PMID: 34070336     DOI: 10.3390/jcm10112287

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  46 in total

Review 1.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

2.  Moyamoya disease.

Authors:  Andrea Gioppo; Francesco Acerbi; Anna Bersano; Giuseppe Faragò
Journal:  Pract Neurol       Date:  2020-07-03

3.  Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis).

Authors: 
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

Review 4.  Vasculogenic and Angiogenic Pathways in Moyamoya Disease.

Authors:  Gloria Bedini; Kinga G Blecharz; Sara Nava; Peter Vajkoczy; Giulio Alessandri; Michela Ranieri; Francesco Acerbi; Paolo Ferroli; Daria Riva; Silvia Esposito; Chiara Pantaleoni; Nardo Nardocci; Federica Zibordi; Elisa Ciceri; Eugenio A Parati; Anna Bersano
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

5.  Effect of age on outcomes of treatment of unruptured cerebral aneurysms: a study of the National Inpatient Sample 2001-2008.

Authors:  Waleed Brinjikji; Alejandro A Rabinstein; Giuseppe Lanzino; David F Kallmes; Harry J Cloft
Journal:  Stroke       Date:  2011-03-24       Impact factor: 7.914

6.  Moyamoya disease in adults: the role of cerebral revascularization.

Authors:  Gregory J Zipfel; Douglas J Fox; Dennis J Rivet
Journal:  Skull Base       Date:  2005-02

7.  Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease.

Authors:  Peicong Ge; Qian Zhang; Xun Ye; Xingju Liu; Xiaofeng Deng; Rong Wang; Yan Zhang; Dong Zhang; Jizong Zhao
Journal:  World Neurosurg       Date:  2017-01-26       Impact factor: 2.104

8.  Surgical outcomes and predictors of stroke in a North American white and African American moyamoya population.

Authors:  Grant W Mallory; Regina S Bower; Macaulay E Nwojo; Philipp Taussky; Nicholas M Wetjen; Thais C Varzoni; Ricardo A Hanel; Fredric B Meyer
Journal:  Neurosurgery       Date:  2013-12       Impact factor: 4.654

9.  Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial.

Authors:  Susumu Miyamoto; Takashi Yoshimoto; Nobuo Hashimoto; Yasushi Okada; Ichiro Tsuji; Teiji Tominaga; Jyoji Nakagawara; Jun C Takahashi
Journal:  Stroke       Date:  2014-03-25       Impact factor: 7.914

10.  Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells.

Authors:  Francesca Tinelli; Sara Nava; Francesco Arioli; Gloria Bedini; Emma Scelzo; Daniela Lisini; Giuseppe Faragò; Andrea Gioppo; Elisa F Ciceri; Francesco Acerbi; Paolo Ferroli; Ignazio G Vetrano; Silvia Esposito; Veronica Saletti; Chiara Pantaleoni; Federica Zibordi; Nardo Nardocci; Maria Luisa Zedde; Alessandro Pezzini; Vincenzo Di Lazzaro; Fioravante Capone; Maria Luisa Dell'Acqua; Peter Vajkoczy; Elisabeth Tournier-Lasserve; Eugenio A Parati; Anna Bersano; Laura Gatti
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.